Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial FibrillationOriginal Manuscript Published on 2023-06-062024-09-05 Journal: Clinical and applied thrombosis/hemostasis : offic [Category] update2024, [키워드] Atrial fibrillation COVID-19 edoxaban Low-molecular-weight heparin [DOI] 10.1177/10760296231180865 PMC 바로가기 [Article Type] Original Manuscript
Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter studyOriginal Article Published on 2023-02-252024-09-05 Journal: Revista española de anestesiología y reanimació [Category] update2024, [키워드] Complicaciones hemorrágicas Complicaciones trombóticas COVID-19 critically ill patients Haemorrhagic complications Heparina de bajo peso molecular Low-molecular-weight heparin Paciente crítico Thromboprohylaxis Thrombotic complications Tromboprofilaxis [DOI] 10.1016/j.redare.2023.02.004 PMC 바로가기 [Article Type] Original Article
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forumCOVID-19 대유행 중 혈전색전증 예방 및 항응고 요법: 항응고 포럼에서 업데이트된 임상 지침Article Published on 2022-08-012022-09-12 Journal: Journal of Thrombosis and Thrombolysis [Category] MERS, 진단, [키워드] anticoagulant therapy anticoagulation approach Aspirin clinical evidence clinical trial condition Consensus COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 vaccination Direct Direct oral anticoagulant Direct-acting oral anticoagulant enoxaparin Evidence Forum Guidance hospitalized patients In-hospital Low-molecular-weight heparin North observational study Patient patients hospitalized patients with COVID-19 Pregnancy Prophylactic Prophylaxis provide provided rivaroxaban. stewardship Thrombophilia Thromboprophylaxis Thrombosis and thrombocytopenia syndrome thrombotic Venous Thromboembolism [DOI] 10.1007/s11239-022-02643-3 PMC 바로가기 [Article Type] Article
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study코로나바이러스 질병 2019에서 저분자량 헤파린 사용은 바이러스 지속성 감소와 관련이 있습니다: 후향적 다기관 관찰 연구Observational Study Published on 2021-12-012022-09-10 Journal: Cardiovascular Research [Category] SARS, 바이오마커, 임상, [키워드] (cfDNA) 95% confidence interval anticoagulation attenuation Biomarker cell death cell-free DNA cfDNA Chain Reaction Coagulopathy contraindications coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 patient COVID-19-associated coagulopathy D-dimer decrease different time point different time points Effect evaluate evaluated haemostasis hazard ratio heparin Hospitalization Hospitalized hospitalized COVID-19 patient hypercoagulability interquartile interquartile range LMWH Low-molecular-weight heparin marker mechanism Mortality multicentre multivariable Cox regression no effect NOAC oral anticoagulant outcome Patient patients with COVID-19 plasma polymerase chain polymerase chain reaction Quantitative quantitative polymerase chain reaction reduced reduction Region responsible retrospective SARS-CoV-2 viral persistence subset survival the cell Thromboinflammation time Viral viral persistence virus was collected [DOI] 10.1093/cvr/cvab308 PMC 바로가기 [Article Type] Observational Study
Management of Spontaneous Bleeding in COVID-19 Inpatients: Is Embolization Always Needed?Article Published on 2021-09-122022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] addition all subject arterial bleeding clinical conditions collected COVID-19 COVID-19 patient COVID-19 patients Critical Critically ill patient CT scan dimension embolization hematoma hypercoagulable incidence indication Italian Low-molecular-weight heparin microbiologically pandemic Patient patients patients treated Percutaneous percutaneous trans arterial embolization reduce SARS-COV-2 infection severe complication Spontaneous spontaneous bleeding survival therapy thrombotic risk tissue tomography treated Volume [DOI] 10.3390/jcm10184119 PMC 바로가기 [Article Type] Article
Point of care ultrasound (POCUS) in diagnosis of proximal deep vein thrombosis among COVID-19 hospitalized patients with a high rate of low molecular weight heparin prophylaxis저분자량 헤파린 예방치료율이 높은 코로나19 입원환자 근위심부정맥혈전증 진단 시 현장진료초음파(POCUS)Case Reports Published on 2021-08-272022-09-11 Journal: Medicina clínica [Category] SARS, 치료기술, [키워드] anticoagulation Care clinical clinical and laboratory features Complication COVID-19 critical condition Deep vein Deep vein thrombosis detect determine Diagnosis discharged DVT Ecografía Embolia pulmonar English helping heparin Heparina de bajo peso molecular hospitalized COVID-19 patients hospitalized patient ICU intensive care intensive care unit Laboratory features limb LMWH low molecular weight low molecular weight heparin Low-molecular-weight heparin Lower lower limb molecular notable outcome pacientes hospitalizado Patient performed planta Point point-of-care popliteal positive Prescriptions Prevalence Prophylaxis proximal pulmonary Pulmonary embolism receiving screened Screening Sin Spanish suffered thrombosis thrombotic complication Thrombotic complications treat Trombosis venosa profunda Ultrasonography ward was performed were assessed with COVID-19 [DOI] 10.1016/j.medcli.2021.01.012 PMC 바로가기 [Article Type] Case Reports
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacyResearch article Published on 2021-07-012022-10-05 Journal: International journal of biological macromolecules [Category] SARS, 신약개발, [키워드] ACE2 ACE2 binding ACE2angiotensin-converting enzyme 2 Analysis angiotensin-converting enzyme 2 Anti-SARS-CoV-2 Activity antiviral activity Antiviral compound available data CDCCenters for Disease Control and Prevention Cell Centers for Disease Control and Prevention Complete Coronavirus disease 2019 COVID-19 COVID-19coronavirus disease 2019 disrupting drug Drug repurposing Eagle's Minimum Essential Medium Efficacy EMEMEagle's Minimum Essential Medium epithelia evaluated FBSfetal bovine serum FDA FDAU.S. Food and Drug Administration fetal bovine serum high throughput virtual screening HTVShigh throughput virtual screening IC50 identity IDidentity in-silico In-vitro include independent indicated interact Interaction LMWHlow-molecular-weight heparin Low-molecular-weight heparin mutant nasal Neuropilin-1 Novel coronavirus NRP1neuropilin-1 P/Spen strep pandemic Pathogens pathology PBSphosphate-buffered saline PDBProtein Data Bank pen strep phosphate-buffered saline potential transmission Prevent Protein Data Bank RBDReceptor Binding Domain Receptor binding domain reducing reported SARS-CoV-2 SARS-CoV-2 transmission SARS-CoV-2severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus 2 Spike protein Spike proteins Support thrombotic event TMPRSS2transmembrane serine protease 2 transmembrane serine protease 2 Transmission treat U.S. Food and Drug Administration UFHunfractionated heparin unfractionated heparin United States variant viral entry Viremia Virtual screening virus assay with COVID-19 [DOI] 10.1016/j.ijbiomac.2021.04.148 [Article Type] Research article
COVID-19 treatment options: a difficult journey between failed attempts and experimental drugsReview Published on 2021-01-042023-07-02 Journal: Internal and Emergency Medicine [Category] SARS, [키워드] antiviral drugs Low-molecular-weight heparin Remdesivir SARS-CoV2 therapy Tocilizumab [DOI] 10.1007/s11739-020-02569-9 PMC 바로가기 [Article Type] Review
High rates of pulmonary artery occlusions in COVID-19. A meta-analysisMeta-Analysis Published on 2021-01-012023-07-06 Journal: European Journal of Clinical Investigation [Category] SARS, [키워드] COVID-19 Embolism and thrombosis Low-molecular-weight heparin SARS Coronavirus [DOI] 10.1111/eci.13433 PMC 바로가기 [Article Type] Meta-Analysis
From Standard to Escalated Anticoagulant Prophylaxis in Fractured Older Adults With SARS-CoV-2 Undergoing Accelerated Orthopedic SurgeryMedicine Published on 2020-10-152022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] Anticoagulant Anticoagulants Antithrombotic bases cardiovascular complication complications COVID-19 COVID-19 drug treatment daily dose death deaths dosage doubling Efficacy faster femoral fractures High dose high risk highest hospital incidence increased survival infected patient Injury Italian Italy knowledge lombardy Low-molecular-weight heparin mandatory metabolic derangement nine Older orthopedic pandemic pathophysiology Patient patients pharmacological treatment Prevalence Prophylaxis protocol reduction in SARS-CoV-2 SARS-COV-2 infection Seven Spread Standard statistically significant subsequent surgeon surgery surgical Symptom the disease trauma treated Treatment virus [DOI] 10.3389/fmed.2020.566770 PMC 바로가기 [Article Type] Medicine